Found: 126
Select item for more details and to access through your institution.
Risk of bleeding complications with antiplatelet agents: Meta-analysis of 338,191 patients enrolled in 50 randomized controlled trials.
- Published in:
- American Journal of Hematology, 2004, v. 75, n. 1, p. 40, doi. 10.1002/ajh.10451
- By:
- Publication type:
- Article
Rapid platelet inhibition after a single capsule of Aggrenox®: Challenging a conventional full-dose aspirin antiplatelet advantage?
- Published in:
- American Journal of Hematology, 2003, v. 72, n. 4, p. 280, doi. 10.1002/ajh.10290
- By:
- Publication type:
- Article
The FDA and PLATO Investigators death lists: Call for a match.
- Published in:
- International Journal of Clinical Practice, 2021, v. 75, n. 7, p. 1, doi. 10.1111/ijcp.14105
- By:
- Publication type:
- Article
The CYP2C19*1/*2 Genotype Does Not Adequately Predict Clopidogrel Response in Healthy Malaysian Volunteers.
- Published in:
- 2013
- By:
- Publication type:
- Journal Article
The CYP2C19*1/*2 Genotype Does Not Adequately Predict Clopidogrel Response in Healthy Malaysian Volunteers.
- Published in:
- Cardiology Research & Practice, 2013, p. 1, doi. 10.1155/2013/128795
- By:
- Publication type:
- Article
Antiplatelet Properties of Escitalopram in Patients with the Metabolic Syndrome: A Dose-Ranging In Vitro Study.
- Published in:
- Neuropsychopharmacology, 2007, v. 32, n. 11, p. 2369, doi. 10.1038/sj.npp.1301355
- By:
- Publication type:
- Article
Antiplatelet Therapy in ACS and A-Fil.
- Published in:
- 2012
- By:
- Publication type:
- Book Review
Vorapaxar monotherapy for secondary stroke prevention: A call for randomized trial.
- Published in:
- International Journal of Stroke, 2016, v. 11, n. 6, p. 614, doi. 10.1177/1747493016632253
- By:
- Publication type:
- Article
Antiplatelet Therapy in ACS and A-Fib.
- Published in:
- 2013
- By:
- Publication type:
- Book Review
Challenging the FDA Black Box Warning for High Aspirin Dose With Ticagrelor in Patients With Diabetes.
- Published in:
- Diabetes, 2013, v. 62, n. 3, p. 669, doi. 10.2337/db12-0746
- By:
- Publication type:
- Article
Plasma fibronectin during myocardial ischemia-reperfusion: Effects of magnesium, diltiazem, and a novel Mac-1 inhibitor.
- Published in:
- American Journal of Hematology, 1998, v. 57, n. 4, p. 309, doi. 10.1002/(SICI)1096-8652(199804)57:4<309::AID-AJH7>3.0.CO;2-Y
- By:
- Publication type:
- Article
Impact of CYP2C19 Polymorphism on Antiplatelet Potency of Prasugrel 5 and 10 mg Daily Maintenance.
- Published in:
- Cardiology, 2018, v. 140, n. 3, p. 155, doi. 10.1159/000491598
- By:
- Publication type:
- Article
Body Mass Index and Plasma P-Selectin before Coronary Stenting Predict High Residual Platelet Reactivity at 6 Months on Dual Antiplatelet Therapy.
- Published in:
- Cardiology, 2018, v. 139, n. 2, p. 132, doi. 10.1159/000485555
- By:
- Publication type:
- Article
Assessing Vessel Tone during Coronary Artery Spasm by Dual-Acquisition Multidetector Computed Tomography Angiography.
- Published in:
- Cardiology, 2018, v. 139, n. 1, p. 25, doi. 10.1159/000478926
- By:
- Publication type:
- Article
Filing Sources after Oral P<sub>2</sub> Y12 Platelet Inhibitors to the Food and Drug Administration Adverse Event Reporting System (FAERS).
- Published in:
- Cardiology, 2017, v. 138, p. 249, doi. 10.1159/000479786
- By:
- Publication type:
- Article
A Prospective, Randomized, Open-Label, Blinded, Endpoint Study Exploring Platelet Response to Half-Dose Prasugrel and Ticagrelor in Patients with the Acute Coronary Syndrome: HOPE-TAILOR Study.
- Published in:
- Cardiology, 2017, v. 138, p. 201, doi. 10.1159/000478000
- By:
- Publication type:
- Article
Filing Sources after Oral P<sub>2</sub>Y12 Platelet Inhibitors to the Food and Drug Administration Adverse Event Reporting System (FAERS).
- Published in:
- Cardiology, 2017, v. 138, n. 4, p. 249, doi. 10.1159/000479786
- By:
- Publication type:
- Article
A Prospective, Randomized, Open-Label, Blinded, Endpoint Study Exploring Platelet Response to Half-Dose Prasugrel and Ticagrelor in Patients with the Acute Coronary Syndrome: HOPE-TAILOR Study.
- Published in:
- Cardiology, 2017, v. 138, n. 4, p. 201, doi. 10.1159/000478000
- By:
- Publication type:
- Article
Incidence and Causes for Early Ticagrelor Discontinuation: A "Real-World" Dutch Registry Experience.
- Published in:
- Cardiology, 2017, v. 138, n. 3, p. 164, doi. 10.1159/000475705
- By:
- Publication type:
- Article
Predicting Successful Recanalization in Patients with Native Coronary Chronic Total Occlusion: The Busan CTO Score.
- Published in:
- Cardiology, 2017, v. 137, n. 2, p. 83, doi. 10.1159/000455824
- By:
- Publication type:
- Article
Troponin I and D-Dimer for Discriminating Acute Pulmonary Thromboembolism from Myocardial Infarction.
- Published in:
- Cardiology, 2017, v. 136, n. 4, p. 222, doi. 10.1159/000449404
- By:
- Publication type:
- Article
Noninvasive Predictors of Malignant Arrhythmias.
- Published in:
- Cardiology, 2016, v. 135, n. 1, p. 36, doi. 10.1159/000445881
- By:
- Publication type:
- Article
Asymptomatic Pulmonary Embolism after Ablation.
- Published in:
- Cardiology, 2016, v. 134, n. 4, p. 426, doi. 10.1159/000444440
- By:
- Publication type:
- Article
Should the Dose of Antiplatelet Drugs Be Adjusted for Body Weight? The Example of Vorapaxar.
- Published in:
- Cardiology, 2016, v. 133, n. 2, p. 69, doi. 10.1159/000440798
- By:
- Publication type:
- Article
Independent Predictors of Major Adverse Events following Coronary Stenting over 28 Months of Follow-Up.
- Published in:
- Cardiology, 2015, v. 132, n. 3, p. 176, doi. 10.1159/000435909
- By:
- Publication type:
- Article
The Dual Antiplatelet Therapy Trial after the FDA Update: Noncardiovascular Deaths, Cancer and Optimal Treatment Duration.
- Published in:
- Cardiology, 2015, v. 132, n. 2, p. 74, doi. 10.1159/000431356
- By:
- Publication type:
- Article
Response to Dual Antiplatelet Therapy Does Not Impact Bleeding Risks in Patients Undergoing Oral Surgery after Acute Coronary Syndromes.
- Published in:
- Cardiology, 2015, v. 132, n. 2, p. 119, doi. 10.1159/000431355
- By:
- Publication type:
- Article
Late Silent Stent Abscess.
- Published in:
- Cardiology, 2015, v. 132, n. 1, p. 65, doi. 10.1159/000398789
- By:
- Publication type:
- Article
Activated Hemostatic Biomarkers in Patients with Implanted Left Ventricle Assist Devices: Are Heparin and/or Clopidogrel Justified?
- Published in:
- Cardiology, 2015, v. 131, n. 3, p. 172, doi. 10.1159/000375232
- By:
- Publication type:
- Article
Aspirin 'Resistance': Impact on No-Reflow, Platelet and Inflammatory Biomarkers in Diabetics after ST-Segment Elevation Myocardial Infarction.
- Published in:
- Cardiology, 2015, v. 131, n. 1, p. 41, doi. 10.1159/000371793
- By:
- Publication type:
- Article
Impact of Valve Surgery on Serum Osteopontin Levels in Patients with Mitral Regurgitation.
- Published in:
- Cardiology, 2015, v. 130, n. 2, p. 82, doi. 10.1159/000368299
- By:
- Publication type:
- Article
Switching from Generic to Brand Clopidogrel in Male Patients after ST-Elevated Myocardial Infarction.
- Published in:
- Cardiology, 2014, v. 129, n. 2, p. 103, doi. 10.1159/000365140
- By:
- Publication type:
- Article
Thrombin Generation and Platelet Reactivity at Hospital Discharge and 6-Month Outcome after the Acute Coronary Syndrome in Diabetic and Nondiabetic Patients.
- Published in:
- Cardiology, 2014, v. 128, n. 1, p. 25, doi. 10.1159/000356492
- By:
- Publication type:
- Article
Angiographic Outcomes Contradict Platelet Data in the PLATO Trial: Confusion over Official Trial Substudies.
- Published in:
- Cardiology, 2014, v. 127, n. 3, p. 190, doi. 10.1159/000357261
- By:
- Publication type:
- Article
Dyspnea and Reversibility of Antiplatelet Agents: Ticagrelor, Elinogrel, Cangrelor, and Beyond.
- Published in:
- Cardiology, 2013, v. 127, n. 1, p. 20, doi. 10.1159/000354876
- By:
- Publication type:
- Article
Changes of Ticagrelor Formulary Tiers in the USA: Targeting Private Insurance Providers away from Government-Funded Plans.
- Published in:
- Cardiology, 2013, v. 126, n. 3, p. 187, doi. 10.1159/000353810
- By:
- Publication type:
- Article
Gastrointestinal Adverse Events after Dual Antiplatelet Therapy: Clopidogrel Is Safer than Ticagrelor, but Prasugrel Data Are Lacking or Inconclusive.
- Published in:
- Cardiology, 2013, v. 126, n. 1, p. 35, doi. 10.1159/000350961
- By:
- Publication type:
- Article
The Bleeding Risk during Warfarin Therapy Is Associated with the Number of Variant Alleles of CYP2C9 and VKORC1 Genes.
- Published in:
- Cardiology, 2013, v. 125, n. 3, p. 182, doi. 10.1159/000350407
- By:
- Publication type:
- Article
The Effects of Ezetimibe/Simvastatin versus Simvastatin Monotherapy on Platelet and Inflammatory Biomarkers in Patients with Metabolic Syndrome.
- Published in:
- Cardiology, 2013, v. 125, n. 2, p. 74, doi. 10.1159/000347134
- By:
- Publication type:
- Article
Unclassified Pleomorphic and Spindle Cell Pulmonary Neoplasm with Brain Metastases after Prasugrel.
- Published in:
- Cardiology, 2013, v. 124, n. 2, p. 85, doi. 10.1159/000346382
- By:
- Publication type:
- Article
Exploring the Ticagrelor-Statin Interplay in the PLATO Trial.
- Published in:
- Cardiology, 2013, v. 124, n. 2, p. 105, doi. 10.1159/000346151
- By:
- Publication type:
- Article
Mortality in the TRACER and ATLAS ACS 2 Trials: Two More Reasons to Audit Vital Records in PLATO.
- Published in:
- Cardiology, 2012, v. 123, n. 1, p. 11, doi. 10.1159/000342085
- By:
- Publication type:
- Article
Ticagrelor FDA Approval Issues Revisited.
- Published in:
- Cardiology, 2012, v. 122, n. 3, p. 144, doi. 10.1159/000339470
- By:
- Publication type:
- Article
Reply.
- Published in:
- Cardiology, 2011, v. 120, n. 4, p. 236, doi. 10.1159/000336454
- By:
- Publication type:
- Article
The FDA Outlook of Events Reporting after Ticagrelor or Clopidogrel in the PLATO Trial: Impact of Sponsor Censoring Dates, Drug Discontinuation, and Withdrawal of Consent.
- Published in:
- Cardiology, 2011, v. 120, n. 3, p. 169, doi. 10.1159/000335476
- By:
- Publication type:
- Article
Extreme All-Cause Mortality in JUPITER Requires Reexamination of Vital Records.
- Published in:
- Cardiology, 2011, v. 120, n. 2, p. 84, doi. 10.1159/000330507
- By:
- Publication type:
- Article
Early Impact of Prescription Omega-3 Fatty Acids on Platelet Biomarkers in Patients with Coronary Artery Disease and Hypertriglyceridemia.
- Published in:
- Cardiology, 2011, v. 118, n. 3, p. 187, doi. 10.1159/000329300
- By:
- Publication type:
- Article
Reply.
- Published in:
- Cardiology, 2011, v. 118, n. 2, p. 139, doi. 10.1159/000327919
- By:
- Publication type:
- Article
Aspirin Dose and Ticagrelor Benefit in PLATO: Fact or Fiction?
- Published in:
- Cardiology, 2011, v. 117, n. 4, p. 280, doi. 10.1159/000324064
- By:
- Publication type:
- Article
Acute Kidney Infarction Secondary to Intracardiac Thrombus Embolization in a Patient with Ischemic Dilated Cardiomyopathy.
- Published in:
- Cardiology, 2011, v. 117, n. 3, p. 219, doi. 10.1159/000322510
- By:
- Publication type:
- Article